Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

A case of erythema ab igne with histopathological features resembling keratosis lichenoides chronica
Shahin, Ahmad , Mastin, Murphy R., Lehman, Julia S. , Anderson, Katelyn , Shahin, Ahmad B , Coias, Jennifer , Lehman, Julia S

Pediatric Dermatology | August 5, 2024 | Volume: 42 | Issue: 1 | Pages: 196-198

10.1111/pde.15715 | PMID 39098008 Get It

AbstractThis case describes a pediatric patient with a history of ichthyosis vulgaris and global anhidrosis who was diagnosed with erythema ab igne (EAI), a rare dermatosis resulting from chronic heat exposure. After developing progressive, reticulated brown patches on his extremities and abdomen, extensive diagnostic investigations were conducted to rule out autoimmune, vascular, and genetic etiologies. Bloodwork was unrevealing and biopsies showed histologic features closely resembling keratosis lichenoides chronica. Ultimately, after discovering the patient had prolonged exposure to a space heater, the diagnosis of EAI was made. This case underscores the diagnostic challenges in pediatric EAI cases and emphasizes the importance of careful history taking as part of a comprehensive evaluation.
Girk3 deletion increases osteoblast maturation and bone mass accrual in adult male mice
Weaver, Samantha , Oliveira, Haydée Torres de , Arnold, Katherine M. , Zars, Elizabeth L. , Peralta-Herrera, Eduardo , Taylor, Earnest L., Yu, Kanglun , Velasco, Ezequiel Marrón Fernández de , Wickman, Kevin , Bradley, Elizabeth W. , Westendorf, Jennifer J., Weaver, Samantha R , Torres, Haydee M , Bradley, Elizabeth W , McGee‐Lawrence, Meghan E. , Westendorf, Jennifer J.

JBMR Plus | August 4, 2024 | Volume: 8 | Issue: 10 | Pages: No page available

10.1093/jbmrpl/ziae108 | PMID 39228688 Get It

Abstract Osteoporosis and other metabolic bone diseases are prevalent in the aging population. While bone has the capacity to regenerate throughout life, bone formation rates decline with age and contribute to reduced bone density and strength. Identifying mechanisms and pathways that increase bone accrual in adults could prevent fractures and accelerate healing. G protein-gated inwardly rectifying K+ (GIRK) channels are key effectors of G protein-coupled receptor signaling. Girk3 was recently shown to regulate endochondral ossification. Here, we demonstrate that deletion of Girk3 increases bone mass after 18 weeks of age. Male 24-week-old Girk3-/- mice have greater trabecular bone mineral density and bone volume fraction than wildtype (WT) mice. Osteoblast activity is moderately increased in 24-week-old Girk3-/- mice compared to WT mice. In vitro, Girk3-/- bone marrow stromal cells (BMSCs) are more proliferative than WT BMSCs. Calvarial osteoblasts and BMSCs from Girk3-/- mice are also more osteogenic than WT cells, with altered expression of genes that regulate the wingless-related integration site (Wnt) family. Wnt inhibition via Dickkopf-1 (Dkk1) or β-catenin inhibition via XAV939 prevents enhanced mineralization, but not proliferation, in Girk3-/- BMSCs and slows these processes in WT cells. Finally, selective ablation of Girk3 from cells expressing Cre recombinase from the 2.3 kb-Col1a1 promoter, including osteoblasts and osteocytes, is sufficient to increase bone mass and bone strength in male mice at 24 weeks of age. Taken together, these data demonstrate that Girk3 regulates progenitor cell proliferation, osteoblast differentiation, and bone mass accrual in adult male mice.
Simultaneous onset of chronic nonbacterial osteomyelitis in siblings
Patel, Jenny A. , Thomas, Kristen B. , Ristagno, Elizabeth H. , Basiaga, Matthew L.

Modern Rheumatology Case Reports | August 3, 2024 | Volume: 9 | Issue: 1 | Pages: 20-26

10.1093/mrcr/rxae035 | PMID 39096523 Get It

ABSTRACT Chronic nonbacterial osteomyelitis (CNO) is an uncommon autoinflammatory disorder. Significant effort has recently been spent to better define and treat this disorder including development of consensus treatment protocols, validate disease activity tools, and refining classification criteria. However, the underlying immunopathogenesis of the disease remains elusive. In this report, we describe the simultaneous onset of CNO in siblings. A pathogenic gene mutation was not identified, and these sisters lacked a similar biomarker profile. This report highlights that if a genetic predisposition for CNO exists, it may be related to complex polygenic or multifactorial mechanisms of disease evolution.
State inequities: Gaps in planned treatment for criminal legal referrals with opioid use disorder across two decades of US treatment admissions
Bormann, Nicholas L. , Weber, Andrea N. , Oesterle, Tyler , Miskle, Benjamin , Lynch, Alison C., Arndt, Stephan , Oesterle, Tyler S , Bormann, Nicholas L , Lynch, Alison C.

The American Journal on Addictions | August 3, 2024 | Volume: 34 | Issue: 1 | Pages: 60-68

10.1111/ajad.13636 | PMID 39096196 Get It

AbstractBackground and ObjectivesCriminal‐legal (CL) referrals to addiction treatment have historically had low utilization of medications for opioid use disorder (MOUD). While state differences have been reported, an in‐depth longitudinal analysis of state‐by‐state differences is lacking.MethodsThe Substance Abuse and Mental Health Services Administration Treatment Episode Dataset‐Admissions 2000–2020 provided data for individuals entering their initial treatment with an opioid as their primary substance. Outcome was planned use of MOUD, assessing odds ratio (OR) of CL referrals relative to non‐CL referrals cumulatively over the 21‐year period and as incremental change (change in relative disparity) using effect sizes, stratified by each state.Results2,187,447 cases met the criteria. Planned MOUD occurred in 37.7% of non‐CL clients versus 6.5% of CL clients (OR = 0.11, 95% confidence interval = 0.11–0.12). For all clients, planned MOUD increased from 2000 (33.9%) to 2020 (44.8%). This increase was blunted within CL clients, increasing from 2000 (6.4%) to 2020 (13.3%). Rhode Island saw the greatest improvements in equity.Discussion and ConclusionsWhile rates of planned MOUD increased over the 21 years, a significant disparity persisted among CL clients in most states. As opioid use disorders and opioid‐related overdoses are more prevalent among those involved with the CL system, improving this has high impact.Scientific SignificanceProvides the most comprehensive analysis of state‐by‐state inequities in MOUD access for CL relative to non‐CL referrals over a 21‐year period through use of a national data set. Positive outliers are used as case examples for others to follow in pursuit of more equitable care.
Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome
Chinga, Michell Lozano , Bussel, James B. , Fluchel, Mark , Wilkes, Jacob , Meeks, Huong , Meznarich, Jessica , Lozano Chinga, Michell M , Meeks, Huong , Meznarich, Jessica A , Zhang, Chong

Pediatric Blood & Cancer | August 3, 2024 | Volume: 71 | Issue: 10 | Pages: No page available

10.1002/pbc.31239 | PMID 39096193 Get It

AbstractBackgroundImmune thrombocytopenia (ITP) and Evans syndrome (ES) are manifestations of immune dysregulation. Genetic variants in immune‐related genes have been identified in patients with ITP and especially ES. We aimed to explore familial autoimmunity in patients with ITP and ES to understand possible contributions to chronicity.ProcedureWe assessed family history in two ways: via patient report for ITP and ES and by population‐based analysis using the Utah Population Database (UPDB) for ITP. A total of 266 patients with ITP and 21 patients with ES were identified via chart review, and 252 of the 266 patients with ITP were also identified in the UPDB.ResultsChart review showed familial autoimmunity in 29/182 (15.9%) and 25/84 (29.8%) of patients with newly diagnosed+persistent (nd+p) ITP and chronic ITP (cITP), respectively, (p = .009). The UPDB analysis revealed that autoimmunity in relatives of patients with nd+pITP was higher than in relatives of controls (odds ratio [OR]: 1.69 [1.19–2.41], p = .004), but was not significantly increased in relatives of patients with cITP (OR 1.10 [0.63–1.92], p = .734). Incomplete family history in medical records likely contributed to the observed discrepancy.ConclusionsThe findings suggest that familial autoimmunity may have a stronger association with the development of ITP rather than its duration. Twelve (57.1%) patients with ES reported autoimmunity in their relatives. UPDB analysis was omitted due to the small number of patients with ES. The use of population databases offers a unique opportunity to assess familial health and may provide clues about contributors to immune dysregulation features within families.
Association of county level poverty with mortality from primary liver cancers
Ledenko, Matthew , Patel, Tushar , Patel, Tushar

Cancer Medicine | August 3, 2024 | Volume: 13 | Issue: 15 | Pages: No page available

10.1002/cam4.7463 | PMID 39096101 Get It

AbstractBackgroundThe highly variable occurrence of primary liver cancers across the United States emphasize the relevance of location‐based factors. Social determinants such as income, educational attainment, housing, and other factors may contribute to regional variations in outcomes. To evaluate their impact, this study identified and analyzed clusters of high mortality from primary liver cancers and the association of location‐based determinants with mortality across the contiguous United States.MethodsA geospatial analysis of age‐adjusted incidence and standardized mortality rates from primary liver cancers from 2000 to 2020 was performed. Local indicators of spatial association identified hot‐spots, clusters of counties with significantly higher mortality. Temporal analysis of locations with persistent poverty, defined as high (>20%) poverty for at least 30 years, was performed. Social determinants were analyzed individually or globally using composite measures such as the social vulnerability index or social deprivation index. Disparities in county level social determinants between hot‐spots and non‐hot‐spots were analyzed by univariate and multivariate logistic regression.ResultsThere are distinct clusters of liver cancer incidence and mortality, with hotspots in east Texas and Louisiana. The percentage of people living below the poverty line or Hispanics had a significantly higher odds ratio for being in the top quintile for mortality rates in comparison to other quintiles and were highly connected with mortality rates. Current and persistent poverty were both associated with an evolution from non‐hotspots to new hotspots of mortality. Hotspots were predominantly associated with locations with significant levels of socioeconomic vulnerability or deprivation.ConclusionsPoverty at a county level is associated with mortality from primary liver cancer and clusters of higher mortality. These findings emphasize the importance of addressing poverty and related socio‐economic determinants as modifiable factors in public health policies and interventions aimed at reducing mortality from primary liver cancers.
Racial and ethnic disparities in the natural history of alcohol‐associated liver disease in the United States
Ayares, Gustavo , Díaz, Luis Antonio , Fuentes–López, Eduardo , Idalsoaga, Francisco , Cotter, Thomas G. , Dunn, Winston , Shah, Vijay H. , Kamath, Patrick S. , Lazarus, Jeffrey V. , Simonetto, Douglas A , Kamath, Patrick S , Lazarus, Jeffrey V , Bataller, Ramon A , Arrese, Marco , Wong, Robert J , Singal, Ashwani K , Arab, Juan P , Cotter, T G , Díaz, Luis A , Ayares, Gustavo , Dunn, Winston , Simonetto, Douglas A. , Arrese, Marco , Wong, Robert J. , Singal, Ashwani K. , Arab, Juan Pablo

Liver International | August 3, 2024 | Volume: 44 | Issue: 10 | Pages: 2822-2833

10.1111/liv.16023 | PMID 39096099 Get It

Abstract Background Outcomes in alcohol‐associated liver disease (ALD) are influenced by several race and ethnic factors, yet its natural history across the continuum of patients in different stages of the disease is unknown. Methods We conducted a retrospective cohort study of U.S. adults from 2011 to 2018, using three nationally representative databases to examine potential disparities in relevant outcomes among racial and ethnic groups. Our analysis included logistic and linear regressions, along with competing risk analysis. Results Black individuals had the highest daily alcohol consumption (12.6 g/day) while Hispanic participants had the largest prevalence of heavy episodic drinking (33.5%). In a multivariable‐adjusted model, Hispanic and Asian participants were independently associated with a higher ALD prevalence compared to Non‐Hispanic White interviewees (OR: 1.4, 95% CI: 1.1–1.8 and OR: 1.5 95% CI:1.1–2.0, respectively), while Blacks participants had a lower ALD prevalence (OR: .7 95% CI: .6–.9), and a lower risk of mortality during hospitalization due to ALD (OR: .83 95% CI: .73–.94). Finally, a multivariate competing‐risk analysis showed that Hispanic ethnicity had a decreased probability of liver transplantation if waitlisted for ALD (SHR: .7, 95% CI: .6–.8) along with female Asian population (HR: .40, 95% CI: .26–.62). Conclusions After accounting for key social and biological health determinants, the Hispanic population showed an increased risk of ALD prevalence, even with lower alcohol consumption. Additionally, Hispanic and Asian female patients had reduced access to liver transplantation compared to other enlisted patients.
Using multistate models with clinical trial data for a deeper understanding of complex disease processes
Therneau, Terry M. , Ou, Fang‐Shu , Ou, Fang-Shu

Clinical Trials | August 3, 2024 | Volume: 21 | Issue: 5 | Pages: 531-540

10.1177/17407745241267862 | PMID 39095982 Get It

A clinical trial represents a large commitment from all individuals involved and a huge financial obligation given its high cost; therefore, it is wise to make the most of all collected data by learning as much as possible. A multistate model is a generalized framework to describe longitudinal events; multistate hazards models can treat multiple intermediate/final clinical endpoints as outcomes and estimate the impact of covariates simultaneously. Proportional hazards models are fitted (one per transition), which can be used to calculate the absolute risks, that is, the probability of being in a state at a given time, the expected number of visits to a state, and the expected amount of time spent in a state. Three publicly available clinical trial datasets, colon, myeloid, and rhDNase, in the survival package in R were used to showcase the utility of multistate hazards models. In the colon dataset, a very well-known and well-used dataset, we found that the levamisole+fluorouracil treatment extended time in the recurrence-free state more than it extended overall survival, which resulted in less time in the recurrence state, an example of the classic “compression of morbidity.” In the myeloid dataset, we found that complete response (CR) is durable, patients who received treatment B have longer sojourn time in CR than patients who received treatment A, while the mutation status does not impact the transition rate to CR but is highly influential on the sojourn time in CR. We also found that more patients in treatment A received transplants without CR, and more patients in treatment B received transplants after CR. In addition, the mutation status is highly influential on the CR to transplant transition rate. The observations that we made on these three datasets would not be possible without multistate models. We want to encourage readers to spend more time to look deeper into clinical trial data. It has a lot more to offer than a simple yes/no answer if only we, the statisticians, are willing to look for it.
Addressing Breast Cancer Equity Through Virtual Community Oncology Navigation and Engagement (vCONET)
Salinas, Manisha , Odedina, Folakemi T.

Cancer Control | August 3, 2024 | Volume: 31 | Issue: No issue available | Pages: No page available

10.1177/10732748241264711 | PMID 39095960 Get It

Background Breast cancer remains a leading cause of cancer morbidity and mortality worldwide. In the United States, Black women face significant disparities in screening mammograms, experience higher rates of breast cancer at advanced stages, and are more likely to die from the disease. Aims This study aimed to develop and beta-test a virtual health navigation program to enhance breast cancer care within the Black community. We identified barriers to utilizing virtual patient navigators and factors impacting the adoption of virtual navigation for breast cancer information among Black women. Methods The vCONET (Virtual Community Oncology Navigation and Engagement) intervention was delivered through the Second Life virtual platform. The informational content was collaboratively developed with community members. Participants engaged in an informational session on risk factors, mammography information, and preventive behaviors. Surveys (n = 18) and focus groups (n = 9) assessed knowledge and insights into perceptions. Results Findings revealed a positive impact of the intervention, with participants expressing increased knowledge and willingness to seek further information about breast cancer prevention, and highlighted the engaging nature of the virtual environment, while acknowledging potential technological challenges. Conclusion Virtual health navigation shows promise in addressing breast cancer disparities by promoting awareness among Black women. Future efforts should optimize virtual navigation approaches through collaborative engagement for lasting impact, enhancing breast cancer care and equity in communities of color.
QSPC-03 PATIENT-REPORTED QUALITY OF LIFE AFTER UNDERGOING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES: A PROSPECTIVE ASSESSMENT UTILIZING A U.S. NATIONAL REGISTRY
BA, Duy Pham, Sheehan, Darrah, Sheehan, Kimball , Sheehan, Jason P. , MBBS, Konstantinos Katsos, Fadul, Camilo E.

Neuro-Oncology Advances | August 3, 2024 | Volume: 6 | Issue: Supplement_1 | Pages: i37-i37

10.1093/noajnl/vdae090.121 Get It

Abstract Patients with brain metastases (BMETS) frequently emphasize the impact on quality of life (QOL) over prolongation of life at the time of making treatment decisions. Thus, it is critical to evaluate patient-reported health utility scores after treatment of BMETS. Stereotactic surgery (SRS) is becoming the most frequent treatment modality. The objective of this study was to determine the changes in the EuroQol- 5 Dimension (EQ-5D) in patients with BMETS treated with SRS. The NPA SRS Registry is a multi-institutional collaboration prospectively collecting information from patients undergoing SRS since 2017. We queried the registry for the results of the baseline and follow-up EQ-5D questionnaire, with a utility index score given based on the patient’s responses for five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The cohort included 522 cases treated with SRS between 2017 and 2023; 264 (47.8%), 197 (35.7%), and 91 (16.5%) had 1, 2-4, and 5-14 metastases, respectively. The mean EQ-5D score at the time of SRS was 0.551 (SD=0.443). At the last follow-up after SRS, 107 (34.0%) patients indicated improvement from their EQ-5D baseline while 51 (16.2%) were stable. The score decreased in 113 patients (35.9%) while 44 (13.9%) showed mixed changes (i.e., domain sub-scores both increased and decreased). For mobility, usual activities, pain/discomfort, and anxiety/depression domains patients experienced similar rates of improvement (21.0%-22.5%). In the self-care domain, 32 (10.2%) patients reported improvement, 232 (73.7%) reported no change and 89 (28.3%) had worsening scores. Our study provided the first longitudinal prospective real-world data using the EQ-5D, a health utility tool, in patients with BMETS treated with SRS. In more than half of the cases, the patients reported improved or stable EQ-5D scores over time after treatment. Factors independent of treatment that may prompt worsening QOL following SRS are being identified and will be presented.